Suppr超能文献

接种 BNT162b2 mRNA 疫苗前后疱疹病毒在口咽中的脱落。

Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19.

机构信息

Infectious Disease Unit, Samson Assuta Ashdod University Hospital, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel.

Microbiology Laboratory, Samson Assuta Ashdod University Hospital, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel.

出版信息

Vaccine. 2021 Sep 24;39(40):5729-5731. doi: 10.1016/j.vaccine.2021.08.088. Epub 2021 Aug 30.

Abstract

INTRODUCTION

Concerns were raised over an increase in Bell's palsy, herpes simplex and herpes zoster after BNT162b2 vaccination, all are manifestations of herpesviruses reactivation. As herpesviruses commonly reactivate in the oropharynx, we have hypothesized that oropharyngeal shedding of herpesviruses will increase after vaccination.

METHODS

Immune-competent Adults, excluding those using topical steroids or manifesting symptomatic herpesvirus infection, were sampled before BNT162b2 vaccination and one week after. Herpesviruses 1-7 shedding was tested with a multiplexed PCR.

RESULTS

In 103 paired samples the prevalence of herpesviruses was similar before and after vaccination: HSV1, 3.9% vs. 5.8% (p = 0.75); HSV2, 0% vs. 1% (p = not applicable, NA); VZV, 0% vs. 0% (p = NA); EBV, 14.6% vs. 17.5% (p = 0.63); CMV, 0% vs. 0% (p = NA); HHV6, 4.9% vs. 7.8% (p = 0.55); HHV7, 71.8% vs. 72.8% (p = 1); any herpesvirus, 73.8% vs. 74.8% (p = 1).

DISCUSSION

We did not find evidence for increased oropharyngeal reactivation of herpesviruses one week after BNT162b2.

摘要

简介

接种 BNT162b2 后,人们对贝尔氏麻痹、单纯疱疹和带状疱疹的发病率增加提出了担忧,这些都是疱疹病毒再激活的表现。由于疱疹病毒通常在口咽部重新激活,我们假设接种疫苗后口咽部疱疹病毒的脱落会增加。

方法

免疫功能正常的成年人(不包括使用局部类固醇或表现出有症状的疱疹病毒感染的人)在接种 BNT162b2 之前和一周后接受了采样。使用多重 PCR 检测了 1-7 型疱疹病毒的脱落情况。

结果

在 103 对配对样本中,接种前后疱疹病毒的流行率相似:HSV1,3.9% vs. 5.8%(p=0.75);HSV2,0% vs. 1%(p=不适用,NA);VZV,0% vs. 0%(p=NA);EBV,14.6% vs. 17.5%(p=0.63);CMV,0% vs. 0%(p=NA);HHV6,4.9% vs. 7.8%(p=0.55);HHV7,71.8% vs. 72.8%(p=1);任何疱疹病毒,73.8% vs. 74.8%(p=1)。

讨论

我们没有发现接种 BNT162b2 后一周口咽部疱疹病毒再激活增加的证据。

相似文献

5
Herpesviruses and the microbiome.疱疹病毒与微生物组。
J Allergy Clin Immunol. 2013 Dec;132(6):1278-86. doi: 10.1016/j.jaci.2013.02.039. Epub 2013 Apr 20.

引用本文的文献

3
Oral adverse events following COVID-19 and influenza vaccination in Australia.澳大利亚 COVID-19 和流感疫苗接种后的口腔不良事件。
Hum Vaccin Immunother. 2023 Aug;19(2):2253589. doi: 10.1080/21645515.2023.2253589. Epub 2023 Sep 21.

本文引用的文献

5
Bell's palsy and SARS-CoV-2 vaccines.贝尔麻痹与新型冠状病毒2疫苗
Lancet Infect Dis. 2021 Apr;21(4):450-452. doi: 10.1016/S1473-3099(21)00076-1. Epub 2021 Feb 24.
7
Bell's palsy following COVID-19 vaccination.新冠病毒疫苗接种后出现的贝尔麻痹
J Neurol. 2021 Oct;268(10):3589-3591. doi: 10.1007/s00415-021-10462-4. Epub 2021 Feb 21.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验